![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Found 16 studies with search of: | "Gossypol" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Active, not recruiting |
Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
||||
2 | Completed |
Phase 2 Safety and Efficacy Study of AT-101 in Combination With Rituximab in Patients With Chronic Lymphocytic Leukemia
|
||||
3 | Completed |
Safety & Efficacy Study of AT-101 in Combination w/ Rituximab in Previously Untreated Grade I-II Follicular Non-Hodgkin's Lymphoma
|
||||
4 | Active, not recruiting |
Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With Hormone Refractory Prostate Cancer
|
||||
5 | Completed |
Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer
|
||||
6 | Active, not recruiting |
Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
|
||||
7 | Recruiting |
Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery
|
||||
8 | Not yet recruiting |
Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
|
||||
9 | Recruiting |
Gossypol, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer
|
||||
10 | Active, not recruiting |
A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer
|
||||
11 | Recruiting |
Gossypol in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer
|
||||
12 | Suspended |
Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
|
||||
13 | Completed |
Phase II Safety and Efficacy Study of Single-Agent AT-101 in Patients With Relapsed or Refractory B-Cell Malignancies
|
||||
14 | Recruiting |
An Open-Label, Single-Center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer
|
||||
15 | Active, not recruiting |
A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)
|
||||
16 | Completed |
A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer
|